Published in
Elsevier, The Lancet Oncology, 12(20), p. 1670-1680, 2019
DOI: 10.1016/s1470-2045(19)30519-4
Links
Tools
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study
Journal article published in 2019 by
Rina Hui,
Mustafa Özgüroğlu 
,
Augusto Villegas,
Davey Daniel,
David Vicente,
Shuji Murakami,
Takashi Yokoi,
Alberto Chiappori,
Byoung Chul Cho ,
Ki Hyeong Lee,
Jhanelle E. Gray,
Maike de Wit,
Anna Rydén,
Louis Viviers,
Lynne Poole
and other authors.
,
Augusto Villegas,
Davey Daniel,
David Vicente,
Shuji Murakami,
Takashi Yokoi,
Alberto Chiappori,
Byoung Chul Cho ,
Ki Hyeong Lee,
Jhanelle E. Gray,
Maike de Wit,
Anna Rydén,
Louis Viviers,
Lynne Poole
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 